Pyrls Analysis: $500K Raised
What is Pyrls?
Pyrls offers a platform for clinicians and trainees to access drug information, including medication summaries, pharmacotherapy reviews, and drug interaction tools.
Founded
2020
Revenue
$1-5M
Company Stage
Pre-Seed
Investors
- Y Combinator
- Coho Deeptech
YC Batch
W22
Product Features & Capabilities
- Drug Summaries, Pharmacotherapy Reviews, Knowledge Check Assessments, Drug-Drug Interactions Tools, Fully-Automated Keyword Grouping, Backed By 15 Billion Keywords.
How much Pyrls raised
Pre-Seed - $500,000
March 22, 2022Lead Investor: Y Combinator
Who are the founders of Pyrls
DB
Derek Borkowski
Founder
Company Pricing
- Pyrls Free: Free forever, no credit card required
- Pyrls Pro: $15 per month paid yearly or $40 per month paid
Find more companies like Pyrls
See something that needs updating? Suggest edits to this profile.